Early research (Phase 1)Study completedNCT01895491
What this trial is testing
Safety Study of VM206RY in Subjects With Expression of HER2 in Breast Cancer
Who this might be right for
Breast Cancer
Reyon Pharmaceutical Co., Ltd. 9
Showing 20 of 0 results